Medication info
Neotelmi Tablet 40 mg (Telmisartan)

Neotelmi Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
White or nearly white, biconvex round tablet
Packaging
10 tablets/blister x 3, 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201804331 · Approved 2018.10.31 · Insurance code 653805330

Summary

Main use
Treatment of essential hypertension, prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4∼8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral arterial disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension, reducing the burden on blood vessels and the heart. It is also used to decrease the risk of myocardial infarction, stroke, and mortality due to cardiovascular diseases in patients aged 55 or older who are at high risk for cardiovascular conditions. It can be used as an alternative when ACE inhibitors are not suitable. This medication helps maintain cardiovascular health and reduce the risk of complications.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4∼8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause serious harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Pregnant women or women of childbearing age, and nursing mothers should not take this medication. Patients with severely impaired liver function or problems with bile excretion should also avoid this medication. Patients with hereditary angioedema or a history of angioedema should avoid taking this drug. Patients with diabetes or moderate to severe renal impairment should not use specific medications concurrently. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver impairment should use this medication with caution. Caution is required when administered to patients with valvular heart disease or cardiovascular diseases. Patients with renal artery stenosis or severe renal impairment should consult a physician before taking this medication. This drug lowers blood pressure, occasionally causing dizziness, hypotension, syncope, etc.; therefore, symptoms should be carefully monitored while taking it. Serious adverse reactions such as hyperkalemia, renal function deterioration, liver dysfunction, angioedema, interstitial pneumonia, and rhabdomyolysis may occur, and any unusual symptoms should be reported to medical personnel immediately. This medication may enhance the blood pressure-lowering effect if used with other antihypertensive agents, so it should be taken according to the physician's instructions. In particular, combinations with ACE inhibitors and aliskiren are not recommended due to potential risks. Caution is also required when taken with potassium supplements or potassium-sparing diuretics, as serum potassium levels may rise. It is advisable to discontinue this medication 24 hours before surgery. It is not recommended for children and adolescents under 18 years due to insufficient safety and efficacy established. Caution is advised while driving or operating machinery due to risks of dizziness or syncope. Overdosage may result in hypotension, tachycardia, dizziness, acute renal failure, necessitating immediate medical attention. This medication should be stored out of reach of children and should be opened only prior to use.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 82 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • lower back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory abnormalities
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • palpitations
  • nausea
  • lack of effect
  • arrhythmia
  • angioedema
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly closed container. The recommended storage temperature is a room temperature between 1 degree and 30 degrees Celsius. This helps maintain the drug's effectiveness for a longer time.

Appearance and packaging

Appearance

White or nearly white, biconvex round tablet

Package unit

10 tablets/blister x 3, 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.